# Phase II BGG492 Capsule Extension for Partial Epilepsy

> **NCT01338805** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 56 (actual)

## Conditions studied

- Partial Onset Seizures

## Interventions

- **DRUG:** BGG492

## Key facts

- **NCT ID:** NCT01338805
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338805, "Phase II BGG492 Capsule Extension for Partial Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01338805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*